Summary:
Nanoscale technology for the delivery of nucleic acids.

Additional Information:
Chimeros, Inc. is a cancer therapeutics company focused on the development of novel targeted treatments while generating immediate revenues from licensing platform rights and development contracts. Chimeros leverages its diverse scientific team to formulate novel therapeutics. Their technology will lead to improved methods for combating aggressive cancers of the lymphatic system that afflict children and elderly. Chimero's products will address a large market potential by improving the safety and efficacy of current therapeutics.